New York Medicaid: Updated MAT formulary effective as of March 22, 2022
Update: Contact and questions section updated to reflect new chat services
Updated MAT formulary now in effect
As of March 22, 2022, an updated single statewide medication assisted treatment (MAT) formulary is in effect. In accordance with Social Services Law Title 11, Section 364-j (26) (b), managed care providers shall not require prior authorization for any buprenorphine products, methadone or long-acting injectable naltrexone for detoxification or maintenance treatment of a substance use disorder prescribed according to generally accepted national professional guidelines for the treatment of a substance use disorder.
Single statewide MAT formulary effective March 22, 2022 Please take note of the updated MAT formulary as outlined below.
Chat with a live advocate 7 a.m.–7 p.m. CT from the UnitedHealthcare Provider Portal. You can also contact UnitedHealthcare Provider Services at 877-842-3210, TTY/RTT 711, 7 a.m.–5 p.m. CT, Monday–Friday.